[Opinion] EU regulator reiterates positive recommendation for Alzheimer’s drug | Honolulu Star-Advertiser

EU regulator reiterates positive recommendation for Alzheimer’s drug | Honolulu Star-Advertiser

The European Union’s medicines regulator on Friday reiterated its positive recommendation for Eisai and Biogen’s Alzheimer’s drug, Leqembi, after concluding a safety review.

EU regulator reiterates positive recommendation for Alzheimer’s drug

The European Union’s medicines regulator on Friday reiterated its positive recommendation for Eisai and Biogen’s Alzheimer’s drug, Leqembi,…

Alzheimer Europe | European Medicines Agency reaffirms positive opinion on lecanemab to European Commission

European Medicines Agency reaffirms positive opinion on lecanemab to European Commission kellis Fri, 02/28/2025 - 15:34 Science watch Today, the European Medicines Agency has reaffirmed its positive opinion on lecanemab, following discussions at the February Committee for Medicinal Products for Human Use (CHMP) meeting. On 31 January, Biogen and Eisai announced that the European Commission, as part of its decision-making process, had asked the C…

In Germany alone, more than a million people with Alzheimer's disease live. Some of them could help Lecanemab. The drug is about to be approved.The European Medicines Agency (EMA) is once again paving the way for the first Alzheimer's drug in the EU, which aims at the underlying disease processes.The Amsterdam-based authorities have no concerns about safety and recommend the approval of the Lecanemab antibody for the treatment of mild cognitive …